AllSight
Companies · ELAN · Pharmaceutical Preparations

Elanco Animal Health Inc (ELAN)

Elanco Animal Health Inc (ELAN) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Elanco Animal Health Inc (ELAN) stock — financials & valuation

Key numbers for Elanco Animal Health Inc (ELAN): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 37/100 — a percentile rank of Elanco Animal Health Inc’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.

Market cap$11.2B
P / S2.2×
EV / EBITDA14.2×
Gross margin55.4%
Operating margin1.6%
Net margin-4.0%
Return on equity-3.0%
ROIC0.9%
Revenue growth12.0%
Debt / equity0.6×
Dividend yield0.0%

Is Elanco Animal Health Inc overvalued? P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Elanco Animal Health Inc’s own financial statements and shown as context, never as advice.

Aug 5, 2026
Profit beat and outlook rises as product momentum broadens
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact